These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3554801)

  • 1. [Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
    Wollina U; Schlesier F; Schaarschmidt H; Knopf B; Hipler C; Henkel U; Roth H; Bartá U
    Z Hautkr; 1987 Feb; 62(4):313-8. PubMed ID: 3554801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PUVA irradiation decreases the binding of membrane and basement membrane markers to human epidermis in vitro].
    Wollina U; Schaarschmidt H; Schlesier F; Hipler C; Knopf B
    Z Hautkr; 1987 Aug; 62(15):1151-4, 1157-8. PubMed ID: 3314211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
    Steigleder GK; Schulze HJ
    Z Hautkr; 1984 Feb; 59(3):188, 191-2. PubMed ID: 6719977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD; Voss M
    Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
    Schulze HJ; Steigleder GK
    Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
    Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of a tar admixture to dithranol-salicylic-acid-white-petrolatum therapy on the cytokinetics of psoriasis].
    Schulze HJ; Steigleder GK; Pullmann H; Bloedhorn H
    Z Hautkr; 1984 Mar; 59(5):288-90, 295-7. PubMed ID: 6719979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis].
    Bendkowski W; Hadas E; Swietochowska E; Wielkoszyński T; Ostrowska Z; Szapska B
    Pol Merkur Lekarski; 2002 Dec; 13(78):481-3. PubMed ID: 12666446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis.
    Danno K; Yoneda K; Horio T
    Arch Dermatol; 1986 Jul; 122(7):772-8. PubMed ID: 2425750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modified dithranol minute therapy of psoriasis vulgaris].
    Chlebarov S; Rauh M
    Z Hautkr; 1988 Aug; 63(8):658-62. PubMed ID: 3188606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
    Runne U; Kunze J
    Hautarzt; 1985 Jan; 36(1):40-6. PubMed ID: 3972578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
    Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
    J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
    Ernst TM
    Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
    Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
    J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
    Mustakallio KK
    Acta Derm Venereol Suppl (Stockh); 1989; 146():201-2. PubMed ID: 2609870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
    Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
    Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.